Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies

By Argiris Athanassios  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1575-1584

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to 'Gastrin releasing peptide-preferring bombesin binding sites in human lung'

By Lach E.   Coy D.H.   Dumont P.   Landry Y.   Gies J.-P.  

European Journal of Pharmacology, Vol. 273, Iss. 3, 1995-02 ,pp. : 313-313

Elsevier

Access to resources Recommend Favorite

An Update of Radiolabeled Bombesin Analogs for Gastrin-Releasing Peptide Receptor Targeting

By  

Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. : 3329-3341

Bentham Science Publishers

Access to resources Recommend Favorite

A Phase I Trial of Daily Oral 4′-N-Benzoyl-Staurosporine in Combination with Protracted Continuous Infusion 5-Fluorouracil in Patients with Advanced Solid Malignancies

By Eder Jr Joseph P.   Garcia-Carbonero Rocio   Clark Jeffrey W.   Supko Jeffrey G.   Puchalski Thomas A.   Ryan David P.   Deluca Pamela   Wozniak Antoinette   Campbell Angela   Rothermel John   LoRusso Patricia  

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 139-150

Springer Publishing Company

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies

By Deenen Maarten  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1557-1565

Springer Publishing Company

Access to resources Recommend Favorite